about
Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responsesAlterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainPreimplantation Exposure to Bisphenol A and Triclosan May Lead to Implantation Failure in HumansIonotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patientsNeuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathwayExamining the pathways linking chronic sleep restriction to obesityMetabolic parameters and emotionality are little affected in G-protein coupled receptor 12 (Gpr12) mutant micePreventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatmentCentral inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat dietUnique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in RatsAltered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockadeNeuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in MiceIntake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune ActivationDistinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.Probe Sensor Using Nanostructured Multi-Walled Carbon Nanotube Yarn for Selective and Sensitive Detection of Dopamine.Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in ratsAwareness, treatment, control of diabetes mellitus and the risk factors: survey results from northeast China.Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.Gender differences in cognitive function of patients with chronic schizophrenia.Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia.Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.Novel implications of Lingo-1 and its signaling partners in schizophreniaM2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.Muscles within muscles: Coordination of 19 muscle segments within three shoulder muscles during isometric motor tasks.mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional studyG protein-coupled receptor 12 deficiency results in dyslipidemia and obesity in mice.The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophreniaA high-dose Shiitake mushroom increases hepatic accumulation of triacylglycerol in rats fed a high-fat diet: underlying mechanism.Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouseBardoxolone Methyl Prevents Fat Deposition and Inflammation in Brown Adipose Tissue and Enhances Sympathetic Activity in Mice Fed a High-Fat DietMembrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.Lifestyle-gene-drug interactions in relation to the metabolic syndrome.
P50
Q21560808-D0FBDE76-6988-401B-A8C1-3B332CD33815Q21561008-F4523226-42AB-44A9-AEF8-F7ABCA56C284Q26781723-B2D53AF1-3E66-4029-AE81-DD5FB9AD94FFQ28264783-C3D97A86-E735-427A-AE3D-EC14C4D7F1FCQ28285114-D7549F2E-9D49-46F1-9E65-C68CC15E4837Q28382892-99833EFB-0658-4FDB-AA1B-1C8D644971C2Q28482102-AD678018-5E70-4B2B-938F-0ACB87714BC7Q28541531-C59EF24E-056C-43C3-ADF6-09641C26AD05Q28541621-2FECE29B-994D-47AE-B190-0D902647E8E5Q28546441-4DB22856-7E90-4223-8B72-CC2234BF43B8Q28569752-9F4A2352-7F82-4CA2-B26B-E13686A13FFEQ29541297-8C271D4D-D455-471A-B133-90F748FFE7D3Q30370073-C022FC4D-08FF-4150-A8D8-4BBCFF18D8C8Q30468504-F1DFA7DD-9437-46C9-AAC8-E92979A6178AQ33656373-3E590DD8-F310-496F-9ABC-3FF16CE934EEQ33765864-A3CB15B0-9363-4440-B622-57194A07135FQ33961709-B7999A3A-20FC-4E4B-887D-39177707DA97Q34192001-FA2F3AE2-1906-442F-B5F1-FA4BBD3C5491Q34222302-CCED289E-AD75-46B2-BFE1-2D90964C3F97Q34289627-5ED91C47-D8A4-4BA8-B149-991B9DDBAE0CQ34306261-092BFEAF-883E-4F16-A930-054ABF023F44Q34314781-B7068C35-358A-4451-A645-AD0E93D7B5CFQ34332929-FD964DBA-3978-427C-A7F0-5D6AAA1A5053Q34376884-5C9B0509-A272-4B84-BD24-1E795DFCB780Q34399243-19AC74A2-9E87-434C-AFE8-D9E76BCA0881Q34411822-2A592A89-4BFF-4AC4-9CED-4F8E2EBA967FQ34429155-33FC820B-27CF-48CF-8519-31D38F0B450BQ34467470-32BD3721-B90D-4303-8B73-303B9CD0DA56Q34491359-AE640F53-475C-4E4B-8A04-0B44AC24D1FAQ34513221-891C644C-1D2E-4D8A-8382-0C565C45F596Q34544915-92DA512F-C0E6-4F6C-AC24-6AA9B19C606AQ34553979-FD4044A8-8F35-4EEF-94D6-D424C4A72820Q34614012-730BB580-35A8-471D-B543-8FE1D2FEE3DFQ34805258-C642E15B-D7BE-4069-B865-F531DBFCBDD5Q35069463-F3F03AEA-B1BE-40AD-B62C-62FA74639781Q35102399-4DDF6579-7327-4FDA-86D6-3253C9E1C2D7Q35624356-CF53A764-6028-4740-8C4F-096536EB8C62Q35808984-54AE8B54-E21D-47C9-9708-B0228041E5CBQ36187457-E3AC3BCA-5413-40BF-BD35-93599A3E272AQ36250350-20EB2DFD-6CB2-4BE7-8885-21B94ED1D822
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Xu-Feng Huang
@ast
Xu-Feng Huang
@en
Xu-Feng Huang
@es
Xu-Feng Huang
@fr
Xu-Feng Huang
@nl
Xu-Feng Huang
@sl
type
label
Xu-Feng Huang
@ast
Xu-Feng Huang
@en
Xu-Feng Huang
@es
Xu-Feng Huang
@fr
Xu-Feng Huang
@nl
Xu-Feng Huang
@sl
prefLabel
Xu-Feng Huang
@ast
Xu-Feng Huang
@en
Xu-Feng Huang
@es
Xu-Feng Huang
@fr
Xu-Feng Huang
@nl
Xu-Feng Huang
@sl
P214
P244
P106
P1153
12762323800
P21
P214
P244
P2798
P31
P496
0000-0002-5895-2253
P7859
lccn-n95801282